Skip to main content
Back
Watch Compare

Vivani Medical, Inc.

Data quality: 83%
VANI
Nasdaq Manufacturing Measuring & Analyzing Instruments
$1.04
▼ $0.03 (-2.36%)
Mkt Cap: 87.61 M
Price
$1.04
Mkt Cap
87.61 M
Day Range
$1.04 — $1.07
52-Week Range
$0.92 — $1.92
Volume
34,390
Open $1.07
50D / 200D Avg
$1.22
15.25% below
50D / 200D Avg
$1.34
23.00% below

Quick Summary

Key Takeaways

Negative free cash flow of -25.49 M

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-855.73%
Below sector avg (-51.02%)
ROIC-107.76%
Net MarginN/A
Op. MarginN/A

Safety

Debt / Equity
N/A
Current Ratio0.61
Interest CoverageN/A

Valuation

PE (TTM)
-3.29
Below sector avg (-1.98)
P/B Ratio66.93
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (44 peers)
Metric Stock Sector Median
P/E -3.3 -2.0
P/B 66.9 5.1
ROE % -855.7 -51.0
Net Margin % — -150.2
Rev Growth 5Y % — 9.3
D/E — 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -26.61 M
ROE -855.73% ROA -98.64%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -25.49 M
ROIC -107.76% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0.61
Interest Coverage N/A Asset Turnover N/A
Working Capital -2.66 M Tangible Book Value 1.31 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -3.29 Forward P/E N/A
P/B Ratio 66.93 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -29.10%
Market Cap 87.61 M Enterprise Value 84.98 M
Per Share
EPS (Diluted TTM) -0.43 Revenue / Share N/A
FCF / Share -0.30 OCF / Share -0.29
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 95.81%
SBC-Adj. FCF -26.98 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — — —
Net Income -26.61 M -23.49 M -25.65 M -13.89 M -8.92 M
EPS (Diluted) -0.43 -0.43 — — —
Gross Profit — — — — 130,000.0
Operating Income -27.56 M -24.68 M -26.97 M -21.24 M -8.93 M
EBITDA — — — — —
R&D Expenses 18.13 M 15.75 M 16.97 M 14.17 M 2.37 M
SG&A Expenses — — — — —
D&A 424,000.0 400,000.0 357,000.0 381,000.0 70,000.0
Interest Expense — — — — —
Income Tax 2,000.0 — — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 39.39 M 41.56 M 45.80 M 51.13 M 70.88 M
Total Liabilities 23.66 M 23.95 M 25.04 M 6.82 M 2.51 M
Shareholders' Equity 15.73 M 17.61 M 20.76 M 44.31 M 68.37 M
Total Debt — — — — —
Cash & Equivalents 16.23 M 18.35 M 20.65 M — 69.59 M
Current Assets 17.90 M 20.44 M 23.06 M 47.53 M 70.51 M
Current Liabilities 6.60 M 5.99 M 5.72 M 6.82 M 2.46 M